Face, Facial Lipoatrophy With Radiesse, FDA Certifies

by Medindia Content Team on  January 13, 2007 at 4:57 PM AIDS/HIV News
RSS Email Print This Page Comment
Face, Facial Lipoatrophy With Radiesse, FDA Certifies
Rockville-The Food and Drug Administration has given the go-ahead to the new cosmetic filler, Radiesse, to treat chronic facial lipoatrophy, otherwise called fat loss, occurring in patients with AIDS or HIV. This calcium based treatment, is found to assist in the manufacture of collagen.
Advertisement

To ascertain the potential benefits of this filler, FDA embarked on a study of 100 HIV patients suffering facial lipoatrophy. The patients were given a shot of Radiesse and re-examined after six months. The evaluation revealed that 78% of the patients needed minimal fine tuning, yet not more than three injections.

Advertisement
The only side-effects which showed up were short-term inflammation, pain and reddening of the skin.

Source: Medindia
SAV
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions
guest Thursday, August 23, 2007

Where can we find a medical doctor who can inject radiesse in Caracas, Venezuela? Thank you.

guest Monday, March 19, 2007

Where can we find a medical doctor who can inject radiesse in Tunisia. Thanks.

Advertisement

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive